1. Home
  2. CSTE vs SER Comparison

CSTE vs SER Comparison

Compare CSTE & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CSTE

Caesarstone Ltd.

HOLD

Current Price

$1.57

Market Cap

61.9M

Sector

Industrials

ML Signal

HOLD

Logo Serina Therapeutics Inc.

SER

Serina Therapeutics Inc.

HOLD

Current Price

$3.25

Market Cap

42.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSTE
SER
Founded
1987
2017
Country
Israel
United States
Employees
N/A
N/A
Industry
Building Materials
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
61.9M
42.0M
IPO Year
2012
2018

Fundamental Metrics

Financial Performance
Metric
CSTE
SER
Price
$1.57
$3.25
Analyst Decision
Buy
Strong Buy
Analyst Count
1
2
Target Price
$5.00
$13.00
AVG Volume (30 Days)
513.4K
15.1K
Earning Date
11-12-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$400,656,000.00
$116,000.00
Revenue This Year
N/A
$134.46
Revenue Next Year
$1.59
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.86
$3.12
52 Week High
$5.04
$7.92

Technical Indicators

Market Signals
Indicator
CSTE
SER
Relative Strength Index (RSI) 55.28 29.79
Support Level $0.86 $3.15
Resistance Level $1.95 $4.26
Average True Range (ATR) 0.21 0.25
MACD 0.03 -0.03
Stochastic Oscillator 64.49 0.09

Price Performance

Historical Comparison
CSTE
SER

About CSTE Caesarstone Ltd.

Caesarstone Ltd manufactures engineered quartz surfaces. Its products include engineered quartz and porcelain slabs, which are used as kitchen countertops in renovation and remodeling, and residential construction. It also has other applications, including vanity tops, wall panels, backsplashes, floor tiles, stairs, and other interior surfaces that are used in various residential and non-residential applications. The company sells its products under the Caesarstone brand. Caesarstone's geographical segments are the United States, Canada, Latin America, Australia, Asia, Israel, and EMEA(Europe, Middle East, Africa).

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.

Share on Social Networks: